SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors digest record revenue growth and a strong cash position alongside ongoing speculation regarding global commercial expansion and upcoming FDA regulatory catalysts. The community is actively debating the company's long-term fundamentals versus short-term price volatility, with many expressing strong conviction in the firm's pipeline despite heavy short interest.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility and intense community debate as investors react to its slide toward 52-week lows ahead of upcoming quarterly earnings. While the bullish community is highlighting strong product demand, successful international expansion, and the ongoing integration of the Alani Nu brand, bears are expressing concerns over slowing core brand momentum, margin pressure from commodity costs, and increased private-label competition.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant investor interest following a strong first-quarter earnings report that featured a notable EPS beat and raised full-year net income guidance. The community is actively discussing the stock's potential for a breakout, driven by its underlying profitability, expanding institutional partnerships, and high short interest that has sparked speculation about a possible short squeeze.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is driving intense community debate following a mixed shelf offering filing and a rollercoaster earnings reaction that saw the stock swing violently between gains and losses. Investors are divided between those citing massive revenue growth, buyback strength, and AI-driven efficiency as a generational buying opportunity and those concerned by high intraday volatility and the potential for dilution.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing significant investor frustration as earnings performance is overshadowed by concerns over executive leadership and disappointing commentary regarding future sales. Community sentiment is deeply divided, with many traders criticizing management's transparency while bargain hunters view the recent sell-off as an opportunity to accumulate shares at perceived value.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending due to a significant stock price surge following a strong earnings report that topped expectations for both revenue and customer growth. The community is actively discussing the stock's resilience in the software sector, potential long-term benefits from AI infrastructure demands, and the reliability of its observability platform despite broader concerns about software sector valuations.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending following a surge in trading volume and investor interest sparked by a report highlighting its role as a key supplier for AI infrastructure and optics. The community is actively debating the sustainability of this rally, with discussions centered on potential institutional positioning, the impact of heavy call option activity, and the company's long-term integration into advanced data center technologies.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as investors react to a major leadership overhaul and the acquisition of Kezar Life Sciences. The market is actively debating whether these aggressive moves under new management signal an accelerated path toward a potential buyout or a strategic shift in long-term pipeline development.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant volatility following an unexpected FAERS report regarding a patient death, which sparked a sharp sell-off before a rapid recovery as the event was deemed unrelated to their treatment. The community remains deeply divided, with bulls pointing to the company's strong revenue and upcoming pipeline readouts as catalysts for a potential short squeeze, while bears continue to highlight regulatory skepticism and skepticism toward the efficacy of their flagship therapy.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending after receiving a second Complete Response Letter from the FDA for its tabelecleucel therapy, sparking intense debate among retail traders regarding its financial runway and the potential for a long-term turnaround via a Type A meeting path. While some community members view the stock as a distressed asset facing inevitable dilution, others are actively scouting for entry points, citing the drug's established approval in Europe and the possibility of a strategic partnership or buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BKV Corporation Reports First Quarter 2026 Financial and Operational Results

BKV Corporation (BKV or the Company) (NYSE: BKV), today reported financial and operational results for the first quarter of 2026. First Quarter 2026 Highlights Net income attributable to BKV of $44.1 million or $0.42 per diluted share Adjusted Net Income attributable to BKV of $22.4 million or...

Excelerate Energy (EE) Misses Q1 Earnings Estimates

Excelerate Energy (EE) delivered earnings and revenue surprises of -4.32% and +26.30%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Sempra to Report Q1 Results: What's in Store for the Stock?

SRE's Q1 outlook hinges on interim rates, rate-base growth and infrastructure investments, as consensus calls for higher EPS and revenues.

BKV's Insider Sale Was Pre-Planned. The Catalysts to Watch Aren't

Key Points25,000 shares were sold directly for a transaction value of ~$774,000 at around $30.96 per share on May 1, 2026...

Murphy Oil to Post Q1 Earnings: What Should Investors Expect?

MUR heads into the Q1 results with revenues and EPS seen lower, but production guidance, higher commodity prices and cost cuts could shape results.

BKV (NYSE:BKV) Insider Eric Jacobsen Sells 25,000 Shares

BKV Corporation (NYSE:BKV - Get Free Report) insider Eric Jacobsen sold 25,000 shares of BKV stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $30.96, for a total value of $774,000.00. Following the sale, the insider directly owned 252,843 shares in the...

TC Energy (TRP) Q1 Earnings Surpass Estimates

TC Energy (TRP) delivered earnings and revenue surprises of +2.56% and -4.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Short Interest in BKV Corporation (NYSE:BKV) Decreases By 17.5%

BKV Corporation (NYSE:BKV - Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totaling 3,820,363 shares, a decrease of 17.5% from the March 31st total of 4,631,566 shares. Based on an average daily trading...

Analysts Estimate BKV (BKV) to Report a Decline in Earnings: What to Look Out for

BKV (BKV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BKV (NYSE:BKV) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered BKV from a "hold" rating to a "sell" rating in a research note on Saturday...

$BKV Q1 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.42 up 145.16% YoY
• Reported revenue of $432.85M up 449.16% YoY
• BKV forecasts Q2 2026 total capital expenditures of $155-$215 million and net production of 925-975 MMcfe/d. Full-year 2026 Power Adjusted EBITDAX is guided to $135-$175 million, reflecting BKV&#39;s strategic focus.

Stocktwits

BKV Corp

 Q1 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.42 up 145.16% YoY
• Reported revenue of $432.85M up 449.16% YoY
• BKV forecasts Q2 2026 total capital expenditures of $155-$215 million and net production of 925-975 MMcfe/d. Full-year 2026 Power Adjusted EBITDAX is guided to $135-$175 million, reflecting BKV's strategic focus.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

BKV  Earnings Call

BKV Corp. engages in the production of natural gas from owned and operated upstream businesses. It is also involved in the natural gas gathering, processing and transportation, power generation, and carbon capture, utilization, and sequestration. The company was founded by Christopher P. Kalnin in 2015 and is headquartered in Denver, CO.

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

BKV
BKV Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Earnings Recap

Latest BKV News

BKVBKV Corp